Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


09.01.2017

1 Am J Surg
3 Ann Oncol
2 Ann Surg
4 Ann Surg Oncol
5 Anticancer Res
1 BMC Cancer
3 Br J Cancer
2 Cancer
2 Cancer Lett
3 Clin Cancer Res
2 Eur J Cancer
5 Gastrointest Endosc
2 Hum Pathol
2 Int J Cancer
18 Int J Colorectal Dis
3 Int J Oncol
1 J Natl Cancer Inst
1 J Pathol
2 N Engl J Med
1 Nat Rev Cancer
1 Oncogene
7 Oncol Rep
2 Oncology
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. THURAISINGAM R, Jandova J, Pandit V, Michailidou M, et al
    Assessing the national trends in colon cancer among Native Americans: A 12 year SEER database study.
    Am J Surg. 2016 Nov 22. pii: S0002-9610(16)30921.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. TAIEB J, Balogoun R, Le Malicot K, Tabernero J, et al
    Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients.
    Ann Oncol. 2016 Dec 28. pii: mdw687. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. SCHUURHUIZEN CS, Braamse AM, Konings IR, Sprangers MA, et al
    Does severe toxicity affect global quality of life in patients with metastatic colorectal cancer during palliative systemic treatment? A systematic review.
    Ann Oncol. 2016 Dec 19. pii: mdw617. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. SELIGMANN JF, Fisher D, Smith CG, Richman SD, et al
    Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: Analysis from 2530 patients in randomised clinical trials.
    Ann Oncol. 2016.
    PubMed     Text format     Abstract available


    Ann Surg

  5. LEUNG U, Gonen M, Allen PJ, Kingham TP, et al
    Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
    Ann Surg. 2017;265:158-165.
    PubMed     Text format     Abstract available

  6. YAMASHITA S, Brudvik KW, Kopetz SE, Maru D, et al
    Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases.
    Ann Surg. 2016 Dec 19. doi: 10.1097/SLA.0000000000002087.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  7. TARANTINO I, Huttner FJ, Warschkow R, Schmied BM, et al
    Prognostic Relevance of Mucinous Subtype in a Population-based Propensity Score Analysis of 40,083 Rectal Cancer Patients.
    Ann Surg Oncol. 2016;23:1576-86.
    PubMed     Text format     Abstract available

  8. XIE D, Yu C, Gao C, Osaiweran H, et al
    An Optimal Approach for Laparoscopic D3 Lymphadenectomy Plus Complete Mesocolic Excision (D3+CME) for Right-Sided Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available

  9. NAGATA H, Ishihara S, Hata K, Murono K, et al
    Survival and Prognostic Factors for Metachronous Peritoneal Metastasis in Patients with Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available

  10. COLOMBO PE, Bertrand MM, Alline M, Boulay E, et al
    Robotic Versus Laparoscopic Total Mesorectal Excision (TME) for Sphincter-Saving Surgery: Is There Any Difference in the Transanal TME Rectal Approach? : A Single-Center Series of 120 Consecutive Patients.
    Ann Surg Oncol. 2016;23:1594-600.
    PubMed     Text format     Abstract available


    Anticancer Res

  11. IMAI T, Oue N, Sentani K, Sakamoto N, et al
    KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells.
    Anticancer Res. 2017;37:47-55.
    PubMed     Text format     Abstract available

  12. PARK M, Sundaramoorthy P, Sim JJ, Jeong KY, et al
    Synergistically Anti-metastatic Effect of 5-Flourouracil on Colorectal Cancer Cells via Calcium-mediated Focal Adhesion Kinase Proteolysis.
    Anticancer Res. 2017;37:103-114.
    PubMed     Text format     Abstract available

  13. FUJIYOSHI K, Yamamoto G, Takenoya T, Takahashi A, et al
    Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.
    Anticancer Res. 2017;37:239-247.
    PubMed     Text format     Abstract available

  14. PASQUALETTI F, Montrone S, Vivaldi C, Zani M, et al
    Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer.
    Anticancer Res. 2017;37:315-319.
    PubMed     Text format     Abstract available


  15. Non-coding RNAs in Colorectal Cancer.
    Anticancer Res. 2017;37:369.
    PubMed     Text format    


    BMC Cancer

  16. AL-KHAYAL K, Alafeefy A, Vaali-Mohammed MA, Mahmood A, et al
    Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through ROS generation and inhibits cell migration.
    BMC Cancer. 2017;17:4.
    PubMed     Text format     Abstract available


    Br J Cancer

  17. AQUINA CT, Mohile SG, Tejani MA, Becerra AZ, et al
    The impact of age on complications, survival, and cause of death following colon cancer surgery.
    Br J Cancer. 2017 Jan 5. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available

  18. CRISTOBAL I, Torrejon B, Madoz-Gurpide J, Rojo F, et al
    Comment on 'MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells'.
    Br J Cancer. 2016 Dec 20. doi: 10.1038/bjc.2016.
    PubMed     Text format    

  19. CHANDRASEKARAN KS, Sathyanarayanan A, Karunagaran D
    Reply: Comment on 'MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells'.
    Br J Cancer. 2016 Dec 20. doi: 10.1038/bjc.2016.
    PubMed     Text format    


    Cancer

  20. HOFFMAN AS, Lowenstein LM, Kamath GR, Housten AJ, et al
    An entertainment-education colorectal cancer screening decision aid for African American patients: A randomized controlled trial.
    Cancer. 2016 Dec 21. doi: 10.1002/cncr.30489.
    PubMed     Text format     Abstract available

  21. MULLER CJ, Robinson RF, Smith JJ, Jernigan MA, et al
    Text message reminders increased colorectal cancer screening in a randomized trial with Alaska Native and American Indian people.
    Cancer. 2016 Dec 21. doi: 10.1002/cncr.30499.
    PubMed     Text format     Abstract available


    Cancer Lett

  22. LI Y, Oliver PG, Lu W, Pathak V, et al
    SRI36160 is a specific inhibitor of Wnt/beta-catenin signaling in human pancreatic and colorectal cancer cells.
    Cancer Lett. 2016 Dec 30. pii: S0304-3835(16)30800.
    PubMed     Text format     Abstract available

  23. CERDA MB, Lloyd R, Batalla M, Giannoni F, et al
    Silencing peroxiredoxin-2 sensitizes human colorectal cancer cells to ionizing radiation and oxaliplatin.
    Cancer Lett. 2016;388:312-319.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  24. FERREIRO-NEIRA I, Torres NE, Liesenfeld LF, Chan CH, et al
    XPO1 Inhibition Enhances Radiation Response in Preclinical Models of Rectal Cancer.
    Clin Cancer Res. 2016;22:1663-73.
    PubMed     Text format     Abstract available

  25. HILL EJ, Roberts C, Franklin JM, Enescu M, et al
    Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer.
    Clin Cancer Res. 2016;22:1922-31.
    PubMed     Text format     Abstract available

  26. MEYN RE, Krishnan S, Skinner HD
    Everything Old Is New Again: Using Nelfinavir to Radiosensitize Rectal Cancer.
    Clin Cancer Res. 2016;22:1834-6.
    PubMed     Text format     Abstract available


    Eur J Cancer

  27. SARTORE-BIANCHI A, Pietrantonio F, Amatu A, Milione M, et al
    Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients.
    Eur J Cancer. 2017;71:43-50.
    PubMed     Text format     Abstract available

  28. CREMOLINI C, Casagrande M, Loupakis F, Aprile G, et al
    Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest.
    Eur J Cancer. 2016 Dec 13. pii: S0959-8049(16)32534.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  29. CONG ZJ, Hu LH, Ji JT, Xing JJ, et al
    A long-term follow-up study on the prognosis of endoscopic submucosal dissection for colorectal laterally spreading tumors.
    Gastrointest Endosc. 2016;83:800-7.
    PubMed     Text format     Abstract available

  30. NARAVADI V, Gupta N, Early D, Jonnalagadda S, et al
    Prevalence of advanced histological features and synchronous neoplasia in patients with flat adenomas.
    Gastrointest Endosc. 2016;83:795-9.
    PubMed     Text format     Abstract available

  31. YANO T, Nemoto D, Ono K, Miyata Y, et al
    Gel immersion endoscopy: a novel method to secure the visual field during endoscopy in bleeding patients (with videos).
    Gastrointest Endosc. 2016;83:809-11.
    PubMed     Text format     Abstract available

  32. JAVIA S, Rahimi E, Younes M, Ertan A, et al
    Endoscopic and histologic findings in serrated polyposis syndrome.
    Gastrointest Endosc. 2016;83:839-40.
    PubMed     Text format    

  33. KOMAKI Y, Komaki F, Micic D, Ido A, et al
    Risk of colorectal cancer in chronic liver diseases; a systematic review and meta-analysis.
    Gastrointest Endosc. 2016 Dec 20. pii: S0016-5107(16)30839.
    PubMed     Text format     Abstract available


    Hum Pathol

  34. WANG F, Li P, Feng Y, Hu YL, et al
    Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    Hum Pathol. 2016 Dec 29. pii: S0046-8177(16)30358.
    PubMed     Text format     Abstract available

  35. JANG BG, Kim HS, Chang WY, Bae JM, et al
    Prognostic significance of stromal GREM1 expression in colorectal cancer.
    Hum Pathol. 2016 Dec 29. pii: S0046-8177(16)30360.
    PubMed     Text format     Abstract available


    Int J Cancer

  36. SEFRIOUI D, Vermeulin T, Blanchard F, Chapusot C, et al
    Copy Number Variations in DCC/18q and ERBB2/17q are Associated with Disease-Free Survival in Microsatellite Stable Colon Cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30584.
    PubMed     Text format     Abstract available

  37. ZAMORA-ROS R, Barupal D, Rothwell JA, Jenab M, et al
    Dietary Flavonoid Intake and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30582.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  38. JIMENEZ-GOMEZ LM, Espin-Basany E, Marti-Gallostra M, Sanchez-Garcia JL, et al
    Low anterior resection syndrome: a survey of the members of the American Society of Colon and Rectal Surgeons (ASCRS), the Spanish Association of Surgeons (AEC), and the Spanish Society of Coloproctology (AECP).
    Int J Colorectal Dis. 2016;31:813-23.
    PubMed     Text format     Abstract available

  39. WANG Y, Du C, Zhao M, Li M, et al
    Treatment of colonic transplantation tumor-bearing mice with a high-dose aspirin in a short period of time.
    Int J Colorectal Dis. 2016;31:1099-100.
    PubMed     Text format    

  40. TAN HJ, Chan DY, Seow CS
    Isolated colorectal metastasis to the stomach 10 years after primary resection.
    Int J Colorectal Dis. 2016;31:1095-6.
    PubMed     Text format    

  41. TURATI L, Steccanella F, Petrelli F, Vitali E, et al
    Signet-ring cell carcinoma of the rectum and synchronous renal cell carcinoma in a young man.
    Int J Colorectal Dis. 2016;31:1071-2.
    PubMed     Text format    

  42. KONTOVOUNISIOS C
    The role of masterclasses in surgical oncology training: experience from a colorectal cancer surgery masterclass.
    Int J Colorectal Dis. 2016;31:1065-6.
    PubMed     Text format    

  43. YANG KM, Lim SB, Yu CS, Kim JC, et al
    Severe distal ischemic proctitis with venous congestion following anterior resection for sigmoid colon cancer: the importance of Sudeck's point.
    Int J Colorectal Dis. 2016;31:1051-2.
    PubMed     Text format    

  44. DE FELICE F, Musio D, Tombolini V
    Impact of sphincter invasion on T stage definition in rectal cancer.
    Int J Colorectal Dis. 2016;31:933.
    PubMed     Text format    

  45. MORELLI L, Ceccarelli C, Di Franco G, Guadagni S, et al
    Sexual and urinary functions after robot-assisted versus pure laparoscopic total mesorectal excision for rectal cancer.
    Int J Colorectal Dis. 2016;31:913-5.
    PubMed     Text format    

  46. EMMANUEL A, Haji A
    Complete mesocolic excision and extended (D3) lymphadenectomy for colonic cancer: is it worth that extra effort? A review of the literature.
    Int J Colorectal Dis. 2016;31:797-804.
    PubMed     Text format     Abstract available

  47. AHMED J, Nasir M, Flashman K, Khan J, et al
    Totally robotic rectal resection: an experience of the first 100 consecutive cases.
    Int J Colorectal Dis. 2016;31:869-76.
    PubMed     Text format     Abstract available

  48. LEE JH, Yu CS, Lee JL, Kim CW, et al
    Factors affecting the postoperative morbidity and survival of patients with liver cirrhosis following colorectal cancer surgery.
    Int J Colorectal Dis. 2016.
    PubMed     Text format     Abstract available

  49. KIM CN, Bae SU, Lee SG, Yang SH, et al
    Clinical and oncologic outcomes of totally robotic total mesorectal excision for rectal cancer: initial results in a center for minimally invasive surgery.
    Int J Colorectal Dis. 2016;31:843-52.
    PubMed     Text format     Abstract available

  50. DEBOVE C, Guedj N, Tribillon E, Maggiori L, et al
    Local excision of low rectal cancer treated by chemoradiotherapy: is it safe for all patients with suspicion of complete tumor response?
    Int J Colorectal Dis. 2016;31:853-60.
    PubMed     Text format     Abstract available

  51. YAMANO T, Yoshimura M, Kobayashi M, Beppu N, et al
    Malnutrition in rectal cancer patients receiving preoperative chemoradiotherapy is common and associated with treatment tolerability and anastomotic leakage.
    Int J Colorectal Dis. 2016;31:877-84.
    PubMed     Text format     Abstract available

  52. DU P, Burke JP, Khoury W, Lavery IC, et al
    Factors associated with the location of local rectal cancer recurrence and predictors of survival.
    Int J Colorectal Dis. 2016;31:825-32.
    PubMed     Text format     Abstract available

  53. MARQUES CF, Nahas CS, Ribeiro U Jr, Bustamante LA, et al
    Postoperative complications in the treatment of rectal neoplasia by transanal endoscopic microsurgery: a prospective study of risk factors and time course.
    Int J Colorectal Dis. 2016;31:833-41.
    PubMed     Text format     Abstract available

  54. ZHAO D, Li Y, Wang S, Huang Z, et al
    Laparoscopic versus open surgery for rectal cancer: a meta-analysis of 3-year follow-up outcomes.
    Int J Colorectal Dis. 2016;31:805-11.
    PubMed     Text format     Abstract available

  55. CROMBE T, Bot J, Messager M, Roger V, et al
    Malignancy is a risk factor for postoperative infectious complications after elective colorectal resection.
    Int J Colorectal Dis. 2016;31:885-94.
    PubMed     Text format     Abstract available


    Int J Oncol

  56. BASAK D, Punganuru SR, Srivenugopal KS
    Piperlongumine exerts cytotoxic effects against cancer cells with mutant p53 proteins at least in part by restoring the biological functions of the tumor suppressor.
    Int J Oncol. 2016;48:1426-36.
    PubMed     Text format     Abstract available

  57. HATA T, Mokutani Y, Takahashi H, Inoue A, et al
    Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer.
    Int J Oncol. 2016 Dec 20. doi: 10.3892/ijo.2016.3813.
    PubMed     Text format     Abstract available

  58. KAWAI K, Uemura M, Munakata K, Takahashi H, et al
    Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
    Int J Oncol. 2016 Dec 20. doi: 10.3892/ijo.2016.3814.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  59. TAIEB J, Le Malicot K, Shi Q, Penault Lorca F, et al
    Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


    J Pathol

  60. TORRES S, Garcia-Palmero I, Bartolome RA, Fernandez-Acenero MJ, et al
    Combined miRNA profiling and proteomics demonstrates that different miRNAs target a common set of proteins to promote colorectal cancer metastasis.
    J Pathol. 2017 Jan 5. doi: 10.1002/path.4874.
    PubMed     Text format     Abstract available


    N Engl J Med

  61. TRAN E, Robbins PF, Lu YC, Prickett TD, et al
    T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.
    N Engl J Med. 2016;375:2255-2262.
    PubMed     Text format     Abstract available

  62. HONG TS, Gray PJ, Allen JN, Shellito PC, et al
    Case 39-2016. A 74-Year-Old Man with Rectal Bleeding and a History of Prostate Cancer.
    N Engl J Med. 2016;375:2481-2488.
    PubMed     Text format    


    Nat Rev Cancer

  63. DIENSTMANN R, Vermeulen L, Guinney J, Kopetz S, et al
    Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer.
    Nat Rev Cancer. 2017 Jan 4. doi: 10.1038/nrc.2016.
    PubMed     Text format     Abstract available


    Oncogene

  64. WANG T, Xu X, Xu Q, Ren J, et al
    miR-19a promotes colitis-associated colorectal cancer by regulating tumor necrosis factor alpha-induced protein 3-NF-kappaB feedback loops.
    Oncogene. 2016 Dec 19. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    Oncol Rep

  65. PONNUSAMY S, Lattmann E, Lattmann P, Thiyagarajan T, et al
    Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action.
    Oncol Rep. 2016;35:2097-106.
    PubMed     Text format     Abstract available

  66. SHOJI H, Motegi M, Osawa K, Okonogi N, et al
    Radiofrequency thermal treatment with chemoradiotherapy for advanced rectal cancer.
    Oncol Rep. 2016;35:2569-75.
    PubMed     Text format     Abstract available

  67. WANG T, Ning K, Lu TX, Hua D, et al
    Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancer.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5322.
    PubMed     Text format     Abstract available

  68. ZHANG C, Gong P, Liu P, Zhou N, et al
    Thioridazine elicits potent antitumor effects in colorectal cancer stem cells.
    Oncol Rep. 2016 Dec 14. doi: 10.3892/or.2016.5313.
    PubMed     Text format     Abstract available

  69. FUJIYOSHI K, Yamamoto G, Takahashi A, Arai Y, et al
    High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5323.
    PubMed     Text format     Abstract available

  70. HUANG G, Chen X, Cai Y, Wang X, et al
    miR-20a-directed regulation of BID is associated with the TRAIL sensitivity in colorectal cancer.
    Oncol Rep. 2017;37:571-578.
    PubMed     Text format     Abstract available

  71. JANOWSKI E, Timofeeva O, Chasovskikh S, Goldberg M, et al
    Yttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: Clinical and ccfDNA studies.
    Oncol Rep. 2017;37:57-65.
    PubMed     Text format     Abstract available


    Oncology

  72. NOZAWA H, Ishihara S, Kawai K, Hata K, et al
    Characterization of Conversion Chemotherapy for Secondary Surgical Resection in Colorectal Cancer Patients with Lung Metastases.
    Oncology. 2017;92:135-141.
    PubMed     Text format     Abstract available

  73. YANG CA, Huang HY, Chang YS, Lin CL, et al
    DNA-Sensing and Nuclease Gene Expressions as Markers for Colorectal Cancer Progression.
    Oncology. 2016;92.
    PubMed     Text format     Abstract available


    PLoS One

  74. RAMAKER K, Bade S, Rockendorf N, Meckelein B, et al
    Absence of the Epithelial Glycocalyx As Potential Tumor Marker for the Early Detection of Colorectal Cancer.
    PLoS One. 2016;11:e0168801.
    PubMed     Text format     Abstract available

  75. ZHANG ZY, Li C, Gao W, Yin XW, et al
    A Nomogram to Predict Adequate Lymph Node Recovery before Resection of Colorectal Cancer.
    PLoS One. 2016;11:e0168156.
    PubMed     Text format     Abstract available

  76. VARGAS T, Moreno-Rubio J, Herranz J, Cejas P, et al
    3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients.
    PLoS One. 2016;11:e0168423.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: